Company Profile
Transmedics
2.5
Avg Sentiment
Sentiment Over Time
Analysis Timeline
1.0
Score
2026-03-18
"Revolutionary organ transplantation technology and strong revenue growth, but faces significant short-seller allegations and an ongoing shareholder lawsuit."
4.0
Score
2026-02-08
"Described as a 'wonderful stock' with potential for 'another 3X over the next six to seven years' due to its expanding organ care system and great CEO."